MAKO Surgical Corp. (MAKO) has gained its stock value back in the advanced surgical technology arena and is set to address the health care needs of the future, giving patients and hospitals more predictability and payers more reassurance, says Matt Miksic, Managing Director and Senior Research Analyst at Piper Jaffray & Co.
“MAKO, as much as the stock has gotten hurt in the past year, has come way, way in. We think that it’s a robotic-surgery story that’s going to work. We think they’ve proven on themselves in partial knees. I think they are getting better traction in hips. And looking out over the next couple of hills to where health care is going, it’s one of those ‘going where the puck is going to be’ stocks,” Miksic said.
The advanced surgical technology category is an area that will have many opportunities to move surgeons into newer instruments and tools, thereby helping them operate more accurately, consistently and safely, and MAKO is primed to benefit, Miksic says.
“Patients want more predictable outcomes, hospitals want more predictable supply and costs, and I think ultimately payers are going to want some element of reassurance that the implants are put in with some precision. MAKO is a stock that has gotten beaten up; we like it very much this year,” Miksic said.
Intuitive Surgical, Inc. (ISRG) Could Launch New Robotic Surgery Instrument in 2014
March 24, 2014
The Robotic Surgery Platform
January 15, 2008
Sabra Health Care REIT CEO Rick Matros Details the Sabra Health Care REIT Success Story
August 17, 2018
Robotic Surgical System Using Artificial Intelligence to Cure Baldness: Restoration Robotics, Inc. (NASDAQ:HAIR)
July 23, 2018
Behavioral Economics Strategy Powers High Return Portfolio Managed by Jeffrey S. Pavlik, CIO at Pavlik Capital Management
February 06, 2018
